• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌的分子诊断:综述

Molecular diagnosis of nasopharyngeal carcinoma: a review.

作者信息

Gan Y Y, Fones-Tan A, Chan S H

机构信息

School of Science, NIE, Nanyang Technological University, Singapore.

出版信息

Ann Acad Med Singap. 1996 Jan;25(1):71-4.

PMID:8779550
Abstract

The various antigen complexes of the Epstein-Barr virus (EBV) are broadly classified as the viral capsid antigen (VCA), diffuse early antigen (EA-D), restricted early antigen (EA-R), membrane antigen (MA) and the Epstein-Barr nuclear antigen (EBNA). The different EBV-related diseases may be differentiated according to the reactivity of these different classes of antibodies towards the various classes of antigen complexes. However, with the recent development of molecular biology, it is now known that the individual polypeptides of the different EBV antigen complexes can be used as serological markers for the detection of nasopharyngeal carcinoma (NPC). Among the useful serological markers which have been used in enzyme-linked immunosorbent assay (ELISA) for the detection of NPC are the gp125 from the VCA complex (IgA), pp58 from the EA-D complex (IgG), ribonucleotide reductase (IgG and IgA), DNase (IgA) and thymidine kinase (IgA) from the EA-R complex, gp 250/200 from the MA complex (IgA) and the ZEBRA antigen (IgA).

摘要

爱泼斯坦-巴尔病毒(EBV)的各种抗原复合物大致分为病毒衣壳抗原(VCA)、弥散早期抗原(EA-D)、局限早期抗原(EA-R)、膜抗原(MA)和爱泼斯坦-巴尔核抗原(EBNA)。不同的EBV相关疾病可根据这些不同类别的抗体对各类抗原复合物的反应性来区分。然而,随着分子生物学的最新发展,现已知道不同EBV抗原复合物的各个多肽可作为检测鼻咽癌(NPC)的血清学标志物。在用于酶联免疫吸附测定(ELISA)检测NPC的有用血清学标志物中,有来自VCA复合物的gp125(IgA)、来自EA-D复合物的pp58(IgG)、核糖核苷酸还原酶(IgG和IgA)、来自EA-R复合物的脱氧核糖核酸酶(IgA)和胸苷激酶(IgA)、来自MA复合物的gp 250/200(IgA)以及ZEBRA抗原(IgA)。

相似文献

1
Molecular diagnosis of nasopharyngeal carcinoma: a review.鼻咽癌的分子诊断:综述
Ann Acad Med Singap. 1996 Jan;25(1):71-4.
2
Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.爱泼斯坦-巴尔病毒的天然早期抗原,一种用于鼻咽癌诊断的有前景的抗原。
J Med Virol. 2007 Nov;79(11):1710-21. doi: 10.1002/jmv.20987.
3
Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.用于检测鼻咽癌患者血清中抗爱泼斯坦-巴尔病毒(EBV)免疫球蛋白G(IgG)和IgA抗体水平的EB病毒(EBV)EBNA1和病毒衣壳抗原-p18衍生合成肽的单检测组合:现场筛查选项
J Clin Microbiol. 2006 Apr;44(4):1459-67. doi: 10.1128/JCM.44.4.1459-1467.2006.
4
Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.爱泼斯坦-巴尔病毒核抗原-1和早期抗原抗体的补充血清检测:鼻咽癌初筛的一种可能替代方法。
Oral Oncol. 2008 Aug;44(8):784-92. doi: 10.1016/j.oraloncology.2007.10.003. Epub 2008 Feb 21.
5
Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects.鼻咽癌中爱泼斯坦-巴尔病毒IgG和IgA抗体反应的分子多样性:印度尼西亚、中国和欧洲受试者的比较
J Infect Dis. 2004 Jul 1;190(1):53-62. doi: 10.1086/421245. Epub 2004 May 26.
6
Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.泰国鼻咽癌患者血浆中针对爱泼斯坦-巴尔病毒早期抗原和病毒衣壳抗原的IgA及IgG抗体的意义
Asian Pac J Cancer Prev. 2003 Apr-Jun;4(2):113-8.
7
Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.鼻咽癌患者对重组爱泼斯坦-巴尔病毒抗原的抗体反应:ZEBRA蛋白与早期抗原p54和p138的补充检测
J Clin Microbiol. 2001 Sep;39(9):3164-70. doi: 10.1128/JCM.39.9.3164-3170.2001.
8
Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.2013-2017 年期间北京的抗 EBV 抗体:我们在不同患者中发现了什么。
PLoS One. 2018 Mar 1;13(3):e0193171. doi: 10.1371/journal.pone.0193171. eCollection 2018.
9
Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.血清中EB病毒抗体EA-IgA、Rta-IgG、VCA-IgA及SA的表达及其联合检测在鼻咽癌诊断中的意义
Int J Clin Exp Pathol. 2015 Dec 1;8(12):16104-10. eCollection 2015.
10
Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.建立基于 VCA 和 EBNA1 IgA 的酶联免疫吸附试验组合作为鼻咽癌的首选筛查方法:在中国南方进行的两阶段设计的初步性能研究和大规模筛查。
Int J Cancer. 2012 Jul 15;131(2):406-16. doi: 10.1002/ijc.26380. Epub 2011 Nov 19.

引用本文的文献

1
Negative Prognostic Impact of Smoking on Long-term Survival in Patients With Nasopharyngeal Carcinoma Treated With Curative (Chemo)radiotherapy.吸烟对接受根治性(放化疗)的鼻咽癌患者长期生存的预后影响为负性。
In Vivo. 2023 Jul-Aug;37(4):1775-1785. doi: 10.21873/invivo.13266.
2
Accuracy Evaluation and Comparison of 14 Diagnostic Markers for Nasopharyngeal Carcinoma: A Meta-Analysis.14种鼻咽癌诊断标志物的准确性评估与比较:一项Meta分析
Front Oncol. 2020 Sep 18;10:1779. doi: 10.3389/fonc.2020.01779. eCollection 2020.
3
A role of MMP-14 in the regulation of invasiveness of nasopharyngeal carcinoma.
基质金属蛋白酶-14在调控鼻咽癌侵袭性中的作用。
Tumour Biol. 2015 Nov;36(11):8609-15. doi: 10.1007/s13277-015-3558-0. Epub 2015 Jun 4.
4
Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.鼻咽癌患者对重组爱泼斯坦-巴尔病毒抗原的抗体反应:ZEBRA蛋白与早期抗原p54和p138的补充检测
J Clin Microbiol. 2001 Sep;39(9):3164-70. doi: 10.1128/JCM.39.9.3164-3170.2001.